• LRRC8A–Caveolin-1 Signaling in PDAC Growth

  2026-08-27

  The reference study identifies a cholesterol-dependent LRRC8A–Caveolin-1 complex as a mechanistic link between cell-volume regulation, KRAS/EGFR signaling, ribosome biogenesis, and pancreatic ductal adenocarcinoma growth. By combining genetic and pharmacological perturbation with xenografts and patient-derived organoids, the work positions this membrane-associated axis as a potential vulnerability while clarifying how biosynthetic expansion supports tumor proliferation.

• Spatial Metabolomics Maps Lipid Changes in POCD

  2026-08-26

  The reference study combines cardiopulmonary bypass modeling, Barnes maze testing, spatial mass spectrometry imaging, enzyme mapping, and electron microscopy to connect hippocampal lipid remodeling with postoperative cognitive dysfunction. Its intervention data suggest that correcting iPLA2- and SPT-associated abnormalities with DHA and myriocin can reduce cognitive impairment in rats, while also highlighting important limits for clinical translation.

• BAPTA-AM: Practical Calcium Chelation Guide

  2026-08-26

  BAPTA-AM (SKU B4758) is a cell-permeable calcium chelator for experimentally reducing free intracellular Ca²⁺ and examining calcium-dependent signaling, apoptosis, and live-cell responses. It is appropriate for controlled in vitro workflows and selected cellular models, but should not be interpreted as a calcium-specific reagent in every system because channel blocking, magnesium effects, solvent exposure, and cell-loading variability can influence results.

• TAI-1: A Mechanism-First Hec1 Inhibitor Guide

  2026-08-25

  TAI-1 is a potent Hec1 inhibitor for studying mitotic failure, cancer cell proliferation inhibition, and apoptotic cell death induction. This guide distinguishes its Hec1–Nek2 mechanism from replication-stress biology and translates recent transcription-termination findings into better assay decisions.

• Dasatinib Monohydrate in CML Research

  2026-08-25

  Dasatinib Monohydrate enables controlled studies of BCR-ABL signaling, imatinib resistance, and neutrophil extracellular trap biology. This workflow-oriented guide shows how to separate kinase inhibition from NET-associated phenotypes while improving dose selection, controls, and assay interpretation.

• Sulfo-NHS-SS-Biotin for Cell Surface Mapping

  2026-08-24

  Sulfo-NHS-SS-Biotin combines water-soluble amine reactivity with a cleavable disulfide spacer, enabling both surface-protein capture and reversible interactome analysis. This practical guide connects cell surface labeling, affinity purification, western blotting, and RNase-sensitive domain studies to an experimentally controlled workflow.

• Chloramphenicol and Plasmid Ecology

  2026-08-24

  Chloramphenicol is more than a routine selection antibiotic: it can help researchers interpret plasmid maintenance, selection pressure, and resistance-gene behavior. This article connects its molecular biology use with recent evidence on carbapenemase-gene localization and transfer in Enterobacter cloacae.

• Dasatinib (BMS-354825) Research Workflows

  2026-08-23

  Build reproducible Src and Bcr-Abl kinase experiments with Dasatinib, from phospho-signaling assays to cancer-cell phenotyping and animal-model interpretation. This guide connects validated dose–time observations with practical controls, stock handling, and troubleshooting for prostate, PDAC, CML, and exploratory tumor-biology workflows.

• CD28–ARS2 Control of CD8+ T Cell Metabolism

  2026-08-22

  The reference study identifies a CD28–ARS2 signaling axis that reshapes alternative splicing of PKM in activated CD8+ T cells, favoring PKM2 and enabling flexible glucose utilization. Its findings connect costimulatory signaling to RNA processing, cytokine production, and antitumor activity through a mechanism that is distinct from canonical PI3K signaling.

• Protein A/G Magnetic Co-IP/IP Kit for PINK1

  2026-08-21

  Translate UBC9–PINK1 biology into reproducible co-IP, western blot, and mass spectrometry workflows with magnetic separation and Fc-selective capture. This guide combines an application-focused protocol with controls, optimization ranges, and troubleshooting for protein-complex isolation and antibody purification.

• Cy3 Goat Anti-Human IgG (H+L) Antibody Workflow

  2026-08-20

  Build reproducible human IgG detection workflows for immunofluorescence, tissue staining, flow cytometry, and fluorescent ELISA. This guide connects the Cy3 Goat Anti-Human IgG (H+L) Antibody to antibody-characterization studies while emphasizing controls, instrument fit, and troubleshooting rather than overstating biological conclusions.

• Hoechst 33258 for Tumor Mechanics Assays

  2026-08-20

  Hoechst 33258 is a bis-benzimide DNA stain that can provide nuclear context in live-cell studies of KRas transfer and tumor-cell mechanics. This article explains how to integrate its fluorescence with confocal, optical-tweezer, and cell-cycle workflows without mistaking a nuclear counterstain for a direct reporter of oncogenic transport.

• Sphingosine-1-phosphate Signaling Workflows

  2026-08-19

  Build reproducible S1P assays for receptor-proximal signaling, endothelial behavior, and neuronal apoptosis. This practical guide connects concentration control and orthogonal readouts with the S1PR3–TNF-α–caspase-3 findings reported after intracerebral hemorrhage.

• Fucoidan Downregulates Caveolin-1 in MCF-7

  2026-08-19

  A 2026 study in Algal Research identifies caveolin-1 downregulation as a previously underexplored component of fucoidan activity in MCF-7 breast cancer cells. By combining dose-response cytotoxicity, membrane integrity, clonogenic, migration, and protein-expression assays, the study links this marine polysaccharide to both reduced tumor-cell survival and impaired progression-related behavior.

• CB-5083: A Practical p97 Inhibitor Workflow

  2026-08-18

  Build a mechanism-led workflow around CB-5083 to connect p97 inhibition with ubiquitin accumulation, unfolded protein response signaling, stress-granule dynamics, and cancer-cell vulnerability. The approach combines quantitative cell assays with translational guidance for multiple myeloma research and xenograft studies.

7910 records 1/528 page Next 12345 下5页 Last page